GL1X · GenesisL1 explorer

MolNFT v1 · #109430 · protein

Discovery of benzotriazolo diazepines as orally-active inhibitors of bet bromodomains: crystal structure of BRD4 with cpi-13

4X2I · Bromodomain-containing protein 4: “Discovery of benzotriazolo diazepines as orally-active inhibitors of bet bromodomains: crystal structure of…”. X-ray diffraction, 1 ligand (3X0), 1 pocket (best druggability 0.57). MolNFT v1…

PDB
4X2I
Type
protein
Length
126 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 4
UniProt
O60885
Ligands
3X0
Pockets
1 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 4protein12652% helix, 0% strandO60885

Ligands and binding sites

  • 3X0 · (4R)-6-(4-chlorophenyl)-1,4-dimethyl-5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine · ligand · chains A
  • FMT · Formic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11210.570.83223X0

Compared structures

  • 4X2I · Discovery of benzotriazolo diazepines as orally-active inhibitors of BET bromodomains… · the same entry in another collection · chain A against A, TM-score 1.00
  • O60885 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 4 (O60885) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.